Interaction with alcohol is unknown. Please consult your doctor.

Ergagin 0.125mg Tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Ergagin 0.125mg Tablet should be used with caution during lactation. Breast feeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

It is not known whether Ergagin 0.125mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

There is limited information available on the use of Ergagin 0.125mg Tablet in patients with kidney disease. Please consult your doctor.

There is limited information available on the use of Ergagin 0.125mg Tablet in patients with liver disease. Please consult your doctor.